Related News
Now, chip that can test toxicity of new drugs
Source: Agencies |
September 18, 2011, Sunday
|
Print Edition
Print Edition
US government researchers plan to design a chip that can check whether new drugs are toxic before they are tested in people, potentially speeding up the development of new therapies.
The chip would lump together human cells from the liver, heart, muscles and other organs, then diffuse a drug through them. Multiple readouts would then show how different proteins, genes and other compounds in the cells react to the medicine.
"If things are going to fail, you want them to fail early," Dr Francis Collins, the director of the National Institutes of Health said on Friday. "Now you'll be able to find out much quicker if something isn't going to work."
Collins said a drug's toxicity is one of the most common reasons why promising compounds fail. But animal tests - the usual method of checking a drug before trying it on humans - can be misleading. He said about half of drugs that work in animals may turn out to be toxic for people. And some drugs may in fact work in people even if they fail in animals, meaning potentially important medicines could be rejected.
The project aims to bring together new knowledge from engineering, biology and toxicology.
The cells in the chip will be grouped next to each other so they can interact, much as they would in a human body. The chip will be tested with drugs that are known to be safe, and those that are toxic, to look at how the readouts compare.
The Defense Advanced Research Projects Agency and the NIH will each spend up to US$70 million over five years on their own separate programs to develop the chip.
They will also work with the Food and Drug Administration, the US drugs regulator, which could potentially use the chip to test drugs during the approval process.
It takes an average of 15 years and more than US$1 billion to get approval to sell a drug in the United States.
The chip would lump together human cells from the liver, heart, muscles and other organs, then diffuse a drug through them. Multiple readouts would then show how different proteins, genes and other compounds in the cells react to the medicine.
"If things are going to fail, you want them to fail early," Dr Francis Collins, the director of the National Institutes of Health said on Friday. "Now you'll be able to find out much quicker if something isn't going to work."
Collins said a drug's toxicity is one of the most common reasons why promising compounds fail. But animal tests - the usual method of checking a drug before trying it on humans - can be misleading. He said about half of drugs that work in animals may turn out to be toxic for people. And some drugs may in fact work in people even if they fail in animals, meaning potentially important medicines could be rejected.
The project aims to bring together new knowledge from engineering, biology and toxicology.
The cells in the chip will be grouped next to each other so they can interact, much as they would in a human body. The chip will be tested with drugs that are known to be safe, and those that are toxic, to look at how the readouts compare.
The Defense Advanced Research Projects Agency and the NIH will each spend up to US$70 million over five years on their own separate programs to develop the chip.
They will also work with the Food and Drug Administration, the US drugs regulator, which could potentially use the chip to test drugs during the approval process.
It takes an average of 15 years and more than US$1 billion to get approval to sell a drug in the United States.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
